236 related articles for article (PubMed ID: 24059642)
1. Malic acid supplementation increases urinary citrate excretion and urinary pH: implications for the potential treatment of calcium oxalate stone disease.
Rodgers AL; Webber D; de Charmoy R; Jackson GE; Ravenscroft N
J Endourol; 2014 Feb; 28(2):229-36. PubMed ID: 24059642
[TBL] [Abstract][Full Text] [Related]
2. Dietary treatment of urinary risk factors for renal stone formation. A review of CLU Working Group.
Prezioso D; Strazzullo P; Lotti T; Bianchi G; Borghi L; Caione P; Carini M; Caudarella R; Ferraro M; Gambaro G; Gelosa M; Guttilla A; Illiano E; Martino M; Meschi T; Messa P; Miano R; Napodano G; Nouvenne A; Rendina D; Rocco F; Rosa M; Sanseverino R; Salerno A; Spatafora S; Tasca A; Ticinesi A; Travaglini F; Trinchieri A; Vespasiani G; Zattoni F;
Arch Ital Urol Androl; 2015 Jul; 87(2):105-20. PubMed ID: 26150027
[TBL] [Abstract][Full Text] [Related]
3. Is calcium oxalate nucleation in postprandial urine of males with idiopathic recurrent calcium urolithiasis related to calcium phosphate nucleation and the intensity of stone formation? Studies allowing insight into a possible role of urinary free citrate and protein.
Schwille PO; Schmiedl A; Manoharan M
Clin Chem Lab Med; 2004 Mar; 42(3):283-93. PubMed ID: 15080561
[TBL] [Abstract][Full Text] [Related]
4. Theoretical and laboratory investigations of the effects of hydroxyproline ingestion on the metabolic and physicochemical risk factors for calcium oxalate kidney stone formation in a small group of healthy subjects.
Rodgers A; Cele P; Ravenscroft N; Edmonds-Smith C; Jackson G
Int Urol Nephrol; 2019 Jul; 51(7):1121-1127. PubMed ID: 31161522
[TBL] [Abstract][Full Text] [Related]
5. Urinary citrate and renal stone disease: the preventive role of alkali citrate treatment.
Caudarella R; Vescini F
Arch Ital Urol Androl; 2009 Sep; 81(3):182-7. PubMed ID: 19911682
[TBL] [Abstract][Full Text] [Related]
6. Changes in urinary stone risk factors in hypocitraturic calcium oxalate stone formers treated with dietary sodium supplementation.
Stoller ML; Chi T; Eisner BH; Shami G; Gentle DL
J Urol; 2009 Mar; 181(3):1140-4. PubMed ID: 19152919
[TBL] [Abstract][Full Text] [Related]
7. The effect of sodium bicarbonate upon urinary citrate excretion in calcium stone formers.
Pinheiro VB; Baxmann AC; Tiselius HG; Heilberg IP
Urology; 2013 Jul; 82(1):33-7. PubMed ID: 23602798
[TBL] [Abstract][Full Text] [Related]
8. Enteric hyperoxaluria secondary to small bowel resection: use of computer simulation to characterize urinary risk factors for stone formation and assess potential treatment protocols.
Rodgers AL; Allie-Hamdulay S; Jackson GE; Sutton RA
J Endourol; 2014 Aug; 28(8):985-94. PubMed ID: 24773381
[TBL] [Abstract][Full Text] [Related]
9. The effects of potassium and magnesium supplementations on urinary risk factors of renal stone patients.
Jaipakdee S; Prasongwatana V; Premgamone A; Reungjui S; Tosukhowong P; Tungsanga K; Suwantrai S; Noppawinyoowong C; Maskasame S; Sriboonlue P
J Med Assoc Thai; 2004 Mar; 87(3):255-63. PubMed ID: 15117041
[TBL] [Abstract][Full Text] [Related]
10. [Pathophysiology, diagnosis and conservative therapy in calcium kidney calculi].
Hess B
Ther Umsch; 2003 Feb; 60(2):79-87. PubMed ID: 12649986
[TBL] [Abstract][Full Text] [Related]
11. Effect of Potassium Citrate on Calcium Phosphate Stones in a Model of Hypercalciuria.
Krieger NS; Asplin JR; Frick KK; Granja I; Culbertson CD; Ng A; Grynpas MD; Bushinsky DA
J Am Soc Nephrol; 2015 Dec; 26(12):3001-8. PubMed ID: 25855777
[TBL] [Abstract][Full Text] [Related]
12. Alkali action on the urinary crystallization of calcium salts: contrasting responses to sodium citrate and potassium citrate.
Preminger GM; Sakhaee K; Pak CY
J Urol; 1988 Feb; 139(2):240-2. PubMed ID: 3339718
[TBL] [Abstract][Full Text] [Related]
13. Idiopathic recurrent calcium urolithiasis (IRCU): an acid meal challenge uncovers inappropriate pH of postprandial, fasting and daily urine: a cross-sectional study of male patients providing insight into post- and pre-load urinary stone substances, crystallization risk, presence of stones, renal transport and systemic metabolic factors.
Schwille PO; Wipplinger J
Eur J Med Res; 2008 Jul; 13(7):332-42. PubMed ID: 18700191
[TBL] [Abstract][Full Text] [Related]
14. Hypocitraturia in calcium nephrolithiasis.
Rudman D; Kutner MH; Redd SC; Waters WC; Gerron GG; Bleier J
J Clin Endocrinol Metab; 1982 Dec; 55(6):1052-7. PubMed ID: 7130336
[TBL] [Abstract][Full Text] [Related]
15. Effects of citrate on the different phases of calcium oxalate crystallization.
Tiselius HG; Berg C; Fornander AM; Nilsson MA
Scanning Microsc; 1993 Mar; 7(1):381-9; discussion 389-90. PubMed ID: 8316807
[TBL] [Abstract][Full Text] [Related]
16. Citric acid or citrates in urine: which should we focus on in the prevention of calcium oxalate crystals and stones?
Laube N; Jansen B; Hesse A
Urol Res; 2002 Oct; 30(5):336-41. PubMed ID: 12389124
[TBL] [Abstract][Full Text] [Related]
17. Simulating calcium salt precipitation in the nephron using chemical speciation.
Rodgers AL; Allie-Hamdulay S; Jackson G; Tiselius HG
Urol Res; 2011 Aug; 39(4):245-51. PubMed ID: 21249493
[TBL] [Abstract][Full Text] [Related]
18. Simple dietary advice targeting five urinary parameters reduces urinary supersaturation in idiopathic calcium oxalate stone formers.
Sromicki J; Hess B
Urolithiasis; 2020 Oct; 48(5):425-433. PubMed ID: 32524204
[TBL] [Abstract][Full Text] [Related]
19. Urine citrate and renal stone disease.
Goldberg H; Grass L; Vogl R; Rapoport A; Oreopoulos DG
CMAJ; 1989 Aug; 141(3):217-21. PubMed ID: 2665909
[TBL] [Abstract][Full Text] [Related]
20. Idiopathic hypocitraturic calcium-oxalate nephrolithiasis successfully treated with potassium citrate.
Pak CY; Fuller C
Ann Intern Med; 1986 Jan; 104(1):33-7. PubMed ID: 3940503
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
